Literature DB >> 32912136

A comparison of BeadChip and WGS genotyping outputs using partial validation by sanger sequencing.

Kirill A Danilov1,2, Dimitri A Nikogosov3, Sergey V Musienko3, Ancha V Baranova4,5.   

Abstract

BACKGROUND: Head-to-head comparison of BeadChip and WGS/WES genotyping techniques for their precision is far from straightforward. A tool for validation of high-throughput genotyping calls such as Sanger sequencing is neither scalable nor practical for large-scale DNA processing. Here we report a cross-validation analysis of genotyping calls obtained via Illumina GSA BeadChip and WGS (Illumina HiSeq X Ten) techniques.
RESULTS: When compared to each other, the average precision and accuracy of BeadChip and WGS genotyping techniques exceeded 0.991 and 0.997, respectively. The average fraction of discordant variants for both platforms was found to be 0.639%. A sliding window approach was utilized to explore genomic regions not exceeding 500 bp encompassing a maximal amount of discordant variants for further validation by Sanger sequencing. Notably, 12 variants out of 26 located within eight identified regions were consistently discordant in related calls made by WGS and BeadChip. When Sanger sequenced, a total of 16 of these genotypes were successfully resolved, indicating that a precision of WGS and BeadChip genotyping for this genotype subset was at 0.81 and 0.5, respectively, with accuracy values of 0.87 and 0.61.
CONCLUSIONS: We conclude that WGS genotype calling exhibits higher overall precision within the selected variety of discordantly genotyped variants, though the amount of validated variants remained insufficient.

Entities:  

Keywords:  Genotype concordance; Microarray genotyping; Sanger sequencing; WES; WGS; Whole genome sequencing

Mesh:

Year:  2020        PMID: 32912136      PMCID: PMC7488117          DOI: 10.1186/s12864-020-06919-x

Source DB:  PubMed          Journal:  BMC Genomics        ISSN: 1471-2164            Impact factor:   3.969


Background

Both Whole Genome (WGS) and Whole Exome sequencing (WES) are now used in multiple avenues of clinical and scientific inquiry. Despite increased availability of these techniques and rapid decline of associated costs, their context-dependent per-base performance remained in question. The performance characteristics of WGS/WES include accuracy (the extent of agreement between the reference and the assay-derived nucleic sequence), precision which is broadly defined as repeatability for within-run precision and reproducibility for between-run precision as well as analytical sensitivity, specificity and a reportable range of the reference genome coverage [1]. While the repeatability issues were extensively presented in detail previously [2], the absence of scalable non-NGS (next-generation sequencing) techniques for genotype calling limits evaluations of accuracy. BeadChip genotyping is an efficient and scalable way of genotype resolution, with two inherent limitations: a necessity to decompose binary alleles and confinement to a predefined list of genotyped variants. These two limitations, however, do not prevent its usefulness for a variety of clinical and non-clinical applications [3]. Predefined nature of the variants to be tested makes BeadChip genotyping amenable to validation by either PCR (polymerase chain reaction), or Sanger sequencing which has been recently shown to have limited utility and erroneous behaviour in the validation of NGS variants [4]. A comparison of genotyping calls made by BeadChip and WGS/WES techniques may provide an insight into the possible nature of the discordant calls observed during genotyping quality control stage. Here we attempted to identify analytical issues leading to the discordance in genotyping calls made independently by WGS and BeadChip techniques.

Results

Sequencing statistics

Table 1 lists the sequencing statistics for the three sequenced samples. FastQC reports are available as Additional files 1, 2, 3, 4, 5 and 6 for sample_001, sample_002, sample_003, respectively. Percentage of reads falling into a category with averaged Phred scaled sequencing quality above 30 is shown by %Q. The absence of unpaired reads, repeatability in terms of GC content and more than 90% of bases exceeding sequencing quality of 30 was used as a mark of confidence in data quality.
Table 1

Raw sequencing data statistics summary

SampleRead orientationMean read quality (Phred score)Number of reads% GC% Q > 30Number of bases (1e6)Mean read length (bp)
001R139.3139903635841.0795.5659855.45150.0
R236.7639903635841.2186.1759855.45150.1
002R139.2837590016841.0695.4756385.03150.2
R236.837590016841.2286.3256385.03150.3
003R139.3238582601240.9595.5957873.9150.4
R236.4938582601241.0885.1557873.9150.5

The table describes the raw sequencing data quality metrics for all sequenced samples; GC Guanine-cytosine sequence content

Raw sequencing data statistics summary The table describes the raw sequencing data quality metrics for all sequenced samples; GC Guanine-cytosine sequence content

Mapping statistics

All the data produced by WGS were analyzed for their depth (DOC) and breadth (BOC) of coverage using GATK 3.8 DepthOfCoverage tool [5]. The mean filtered coverage for all three samples exceeded 27x (Fig. 1a–c, Table 2), which complied with recommendations [6]. Repeatability in BOC values for each base quality interval (Fig. 1b, Table 2) and other sequencing metrics (Table 1) proved the quality of the sequencing.
Fig. 1

Whole genome depth of coverage distributions. Metrics for sample_001 (a), sample_002 (b), sample_003 (c) and breadth of coverage for the specified depth thresholds (d) averaged for all three samples are shown with 95% confidence intervals, n = 3

Table 2

WGS coverage statistics for the filtered mapped data

SampleTotal filtered basesMean DOC% bases above 10% bases above 20% bases above 30
0018734711677728.7091.684.854.1
0028639950319528.3991.387.651.3
0038467894042427.8291.583.849.1
Whole genome depth of coverage distributions. Metrics for sample_001 (a), sample_002 (b), sample_003 (c) and breadth of coverage for the specified depth thresholds (d) averaged for all three samples are shown with 95% confidence intervals, n = 3 WGS coverage statistics for the filtered mapped data

Concordance metrics

Percentages of discordant calls per chromosome for each sample are shown in Fig. 2. The average fraction of discordant results among all comparable genotyping results (intersection of BeadChip and WGS obtained genotyping data) was at 0.3317% for sample_001 (male), 0.8448% for sample_002 (female) and 0.7392% for sample_003 (male) which falls within the range reported previously [2]. Both the sequencing quality and mapping quality parameters were reproduced for all three sequenced samples with an average genotype concordance estimate being higher than 99%.
Fig. 2

Fractions of discordant results for three samples. Percentage of discordant results per each chromosome is shown where applicable

Fractions of discordant results for three samples. Percentage of discordant results per each chromosome is shown where applicable

Mapping of analyzed variants

For each pair of BeadChip-genotyped neighboring variants, distance intervals were extracted within both concordant and discordant group to generate pairs of distance values before and after each variant, followed by their visualization. The resulting maps with a Gaussian kernel density estimation are shown in Fig. 3. The observed approximate evenness of distribution for both concordant and discordant variants supported by the visible clusters allocation along the bisectrix of the axes shows that both concordant and discordant variants are evenly distributed across the chromosome length, with no congregation across the genome. The only observed difference in cluster allocation arises from the frequency of observation for the variants from each group. In other words, less frequent discordant group corresponds to lower mapping density and, consequently, to more considerable distances between every two neighboring variants.
Fig. 3

Distance maps for the analyzed samples. a — sample_001, b — sample_002, c — sample_003, concordant and discordant variants are marked in green and orange, respectively

Distance maps for the analyzed samples. a — sample_001, b — sample_002, c — sample_003, concordant and discordant variants are marked in green and orange, respectively Overall randomness of the locations of discordant genotypes across the genome, measured as cluster evenness and cluster center distance from the bisectrix, was high. However, because locations of discordant variants were limited to variants present on the corresponding BeadChip, the comparison with WGS was necessarily limited to the locations of BeadChip genome variants only. For this reason, patterns in discordant genotypes location throughout the genome were only detectable at locations thoroughly covered by variants presented at BeadChip, which generally are outside any complex genomic regions. Because of that, it was unlikely to detect any unevenness in the WGS-derived discordant genotype calls distribution.

Concordance analysis

Calculated confusion matrices for all three analyzed DNA samples are shown in Fig. 4, with metrics values presented in Table 3. These values show high overall concordance in genotyping between both WGS and BeadChip techniques. Detected discordant results may have arisen from ambiguous BeadChip genotyping call within multiallelic sites. Nevertheless, all calculated quality metrics values surpassed the recommended thresholds [6].
Fig. 4

Confusion matrices calculated for the call sets obtained by WGS and BeadChip. WGS was defined as “true” call set, BeadChip — “test” call set, data is shown for sample_001 (male, chromosomes MT, X, Y were excluded from analysis), sample_002 (female, chromosome MT was excluded from analysis) and sample_003 (male, chromosomes MT, X, Y were excluded from analysis)

Table 3

Quality metrics of genotyping comparison between BeadChip and WGS call sets

SampleGenotype concordanceNon-reference genotype concordanceNon-reference genotype sensitivitySensitivityPrecisionSpecificityAccuracy
0010.997830.996160.996870.997830.997830.999250.99928
0020.991560.979730.987730.991560.991560.996960.99718
0030.992530.9850.984020.992530.992530.997420.9975
Confusion matrices calculated for the call sets obtained by WGS and BeadChip. WGS was defined as “true” call set, BeadChip — “test” call set, data is shown for sample_001 (male, chromosomes MT, X, Y were excluded from analysis), sample_002 (female, chromosome MT was excluded from analysis) and sample_003 (male, chromosomes MT, X, Y were excluded from analysis) Quality metrics of genotyping comparison between BeadChip and WGS call sets

Genotyping quality metrics distributions

For all three samples, the distributions of the WGS genotyping metrics were analyzed and compared within the groups formed based on the concordance, variation class and genotype zygosity criteria (data not shown). While differences in mean values were statistically significant (Welch’s t-test, 0.05 p-value threshold) in several groups, distributions themselves exhibited low intergroup divergence. Moreover, for all group comparisons, observed differences were quite small, and their patterns were not uniform, with several groups being insufficiently large, potentially obscuring inter-group dissimilarity. Thus, discordance in genotyping could not be explained by the variance in these quality metrics. When quality metrics were analyzed for the BeadChip calls, some differences in parameters distributions were found. The distinction was remarkable only for the SNV group, as it included the significant amount of all genotyping results and thus could more precisely represent any actual deviations. Inspection of R, Theta and GC scores for both concordant and discordant variants revealed a pattern of discordant variants located close to the borders of the variant clusters (Fig. 5). Importantly, similar clusters are used in the Illumina GenomeStudio software to assign genotypes to variants (AA, AB and BB), and, therefore, any genotype lying far from the cluster centre may be mistakenly assigned an irrelevant designation. This explanation for the observed discordance pattern was, however, relevant only to sample_002 and sample_003. In sample_001, distribution of discordant variants within the clusters was more or less even. Therefore, we conclude that the observed phenomenon requires further examination. Potential finding of the clustering pattern for discordant calls may then be exploited for quality control.
Fig. 5

BeadChip genotyping quality metrics with highlighted Sanger-validated variants. Theta, R, GC Score values for sample_002 are shown; histograms show the corresponding distributions of plotted metrics in a 1-dimensional space; concordant and discordant variants are marked in blue and orange, respectively; genotypes which are not consistent with Sanger sequencing in both WGS and BeadChip results are marked with a star, matches between Sanger and BeadChip are marked with triangles, matches between Sanger and WGS are marked with circles, variants which were not successfully genotyped by Sanger are marked with crosses

BeadChip genotyping quality metrics with highlighted Sanger-validated variants. Theta, R, GC Score values for sample_002 are shown; histograms show the corresponding distributions of plotted metrics in a 1-dimensional space; concordant and discordant variants are marked in blue and orange, respectively; genotypes which are not consistent with Sanger sequencing in both WGS and BeadChip results are marked with a star, matches between Sanger and BeadChip are marked with triangles, matches between Sanger and WGS are marked with circles, variants which were not successfully genotyped by Sanger are marked with crosses

Sanger sequencing

The sliding window approach performed on sample_002 resulted in the mapping of 6 regions containing from 1 to 3 variants successfully genotyped on both WGS and BeadChip platforms and exhibiting discordant genotypes between the used platforms. Locations of these regions and encompassed variants are collated in Tables 4 and 5. A total of 12 discordant variants were selected for validation by Sanger sequencing. These variants were accompanied by 14 concordant variants located closely to discordant variants. These 12 discordant variants included 6 SNVs and 6 INDELs, of which 4 SNVs were of AA vs BB type discordancy, 2 — AA vs AB type, 3 INDELs of II vs DD type and the remaining 3 INDELs of DD vs DI (II vs DI) type. The selection was performed based on the following criteria:
Table 4

The chosen regions for validation by Sanger sequencing for sample_002

ChromosomeStartEndINDELsSNVsTotalGenotypesVartype
BeadChipWGS
1109711850109712150033TGGG3 SNVs
TCTT
CGGG
1109759300109759400101DDII1 INDEL
28566360085663700101DIII1 INDEL
2233671750233671850101IIDI1 INDEL
6160246180160246690033GGAA3 SNVs
TTCC
GGAA
10101010500101010600101DDII1 INDEL
134979250049792600101DDDI1 INDEL
223797380037974170101DDII1 INDEL
Table 5

The designed primers for amplification and sequencing of the chosen regions

ChromosomeOrientationNameSequence 5′3’LengthTmGCStartEndAmplifying lengthN mismatchesMismatch type
1Fchr1_reg1_FAAGCCCTCGGAGTAGCTTTC2059.465510971175510971177439733 SNV
1Rchr1_reg1_RGGCTGGAATCAATAAGCCCC2058.675510971215110971213239733 SNV
1Fchr1_reg2_FTGATGGACAGGATGGAGTTGTAG2359.5547.831097593001097593228511 INDEL
1Rchr1_reg2_RGAGCTGGACTCTTACCGCCTA2161.0257.141097593841097593648511 INDEL
2Fchr2_reg1_FGTGGTCACGGACATGCAGA1960.0157.89856634288566344634411 INDEL
2Rchr2_reg1_RCTGAGCGCTACTCCGTCATC2060.3260.00856637718566375234411 INDEL
2Fchr2_reg2_FCTCTGGACAGAGAGTATTTGGTTG2458.8345.8323367151023367153337011 INDEL
2Rchr2_reg2_RAGGTGGGAGAAATACCAGCAC2159.7252.3823367187923367185937011 INDEL
6Fchr6_FTTTAAGAAGGCAGGGGATTGCT2259.9645.4516024643116024645249033 SNV
6Rchr6_RGCAACTTAAGCCTTCACCAGT2158.7747.6216024692016024690049033 SNV
10Fchr10_FCCTGGAGACTTGCCTTGACC2060.326010101051110101053023311 INDEL
10Rchr10_RCCTCTACAAGACGTGCCAGT2059.405510101074310101072423311 INDEL
13Fchr13_FAAGCTCTTGATGCGGTGGTT2060.2550497924634979248233011 INDEL
13Rchr13_RCACGTATAGCCCGGCGAA1859.5961.11497927924979277533011 INDEL
22Fchr22_FCGAGGGCCCCATATAGGAGA2059.9660379736033797362240811 INDEL
22Rchr22_RGAGTTGGACCAGTACCTGCC2060.0460379740103797399140811 INDEL
Selected SNPs were successfully genotyped using both WGS and BeadChip platforms. Selected SNPs are located close to each other within 500 bp window length (reasonable limit of one Sanger read). Specific primers can be selected for these SNPs-containing region (by Primer-BLAST [7]). The chosen regions for validation by Sanger sequencing for sample_002 The designed primers for amplification and sequencing of the chosen regions The list of designed primers with respective amplification parameters can be found in Table 5. The gDNA of sample_002 was used for amplifying regions of interest (ROIs) in Table 4. All ROIs, except those located on chromosomes 10 and 13, were successfully amplified and Sanger sequenced. The comparison of genotypes obtained via microarray genotyping, whole genome sequencing and Sanger sequencing of the amplified ROIs is shown in Table 6. Sanger-derived genotypes containing only one letter were the ones obtained from only one read. Plus signs denote Sanger genotypes concordant with the WGS-derived genotype, while double plus signs denote concordance of all three genotyping methods. Hashtag represents concordance with the BeadChip-derived genotype, and asterisk — an absence of concordance with any of the tested methods. Sixteen Sanger-resolved diploid genotypes (forward and reverse Sanger chromatograms covered the variant location) out of the 26 listed in Table 6 were used for confusion matrices calculation using Sanger-derived calls as a “truth” call set, which resulted in WGS and BeadChip precision of 0.81 and 0.5, respectively, and the accuracy values of 0.87 and 0.61. Results of Sanger validation may possibly be explained by low complexity or repetitive genomic context which surrounds some of the validated variants, hindering accuracy and precision of either genotyping or read alignment. All the listed variants which were discordant between BeadChip and WGS were plotted (Fig. 5) to reveal possible clustering of discordant variants based on the initial BeadChip genotyping metrics. No clustering of the validated variants was observed. Thus, current analysis did not allow to make any definite conclusions about the clustering of discordant and concordant variants based on their genotyping quality metrics.
Table 6

Sanger validation results for sample_002

rsIDChromosomePosition (GRCh38)BeadChip genotypeWGS genotypeSanger genotype
rs12731384d1109711898TGGGTT
rs1633365c1109711919TCTTTC
rs58877308a1109712113CGGGGG
rs1386876441109759369GGGGG–
rs202018423b1109759339CCCCCC
rs7572930271109759384CCCCC–
rs760279355b1109759346CCCCCC
rs7678098121109759359DDIII–
rs793943411109759361GGGGG–
rs786205634a285663647DIIIII
rs3832043d2233671807IIDIDD
rs144484152a6160246683GGAAAA
rs149262397b6160246574CCCCCC
rs316022a6160246568GGAAAA
rs529525717b6160246473GGGGGG
rs537568133a6160246590TTCCCC
rs549969754b6160246607CCCCCC
rs5550244716160246297GGGGG–
rs563560445b6160246467CCCCCC
rs5638295926160246443GGGGG–
rs5773527956160246460TTTTT–
rs757852385b6160246688AAAAAA
rs7595662846160246458GGGGG–
rs20089633510101010536DDIINA
rs7534209531349792587DDDINA
rs397515367a2237973817DDIIII

aconcordance between Sanger and WGS genotypes

bconcordance between all three genotyping methods

cconcordance between Sanger and BeadChip genotypes

dabsence of concordance between any of the methods

Sanger validation results for sample_002 aconcordance between Sanger and WGS genotypes bconcordance between all three genotyping methods cconcordance between Sanger and BeadChip genotypes dabsence of concordance between any of the methods

Discussion

Although genotype concordance analysis experiments using different sequencing and genotyping platforms have been performed previously [2, 8], no reports on attempts to explain the observed differences were made. Here we tried to scrutinize the underlying genotyping process proxy such as genotyping quality metrics to find a possible explanation for the discordance pattern. Unfortunately, the genotyping discordance of the observed levels (less than 1%) is usually an underestimation, and does not motivate investigations into the nature of the discordant genotype calling. However, we show that discordant genotypes tend to form clusters in a 2-dimensional space, where the most vivid dimensions are the genotyping quality and technical metrics obtained from the BeadChip genotyping pipeline. Therefore, speculation on possibly lower precision of the BeadChip genotyping platform, as compared to WGS-based pipelines, might find a new conceivable basis upon further investigation. Genotype assignment in the array pipelines is based on marker clustering in a 2-dimensional space (clusters A/A, A/B, B/B), which might happen to be erroneous due to poor cluster separation. This clusterization problem may possibly be solved by incorporating additional dimensions into the analyzed genotyping metrics space, which can be exploited for enhancement of the BeadChip genotyping pipeline upon further investigation and vast Sanger validation of the variants.

Conclusions

Here we show the presence of some parametric differences in quality metrics of genotyping performed by WGS and BeadChip. This phenomenon warrants comprehensive investigation by combining genotyping metrics produced by WGS and BeadChip pipelines and extracting patterns in the observed discordance. In clusters, Sanger validation should be performed for genotype resolution.

Methods

Materials

Three human genomic DNA samples, two males and one female, were selected for this comparison. After collection by Oragene DNA saliva-based collection device (DNA Genotek, Canada), genomic DNA was extracted as per the manufacturer protocol and stored frozen in Tris-EDTA buffer at − 20 °C until genotyping was performed.

BeadChip genotyping

Infinium iSelect 24 × 1 HTS Custom Beadchip Kit (GSAsharedCUSTOM_20018389_A2) genotyping was performed using 50 ng of genomic DNA. Microarray fluorescence was scanned using the Illumina iScan system, and the genotype calling was executed using the Illumina GenomeStudio Genotyping Module software (Illumina, USA). No imputation was implemented, and only variants successfully genotyped on the specified array were used in the analysis.

Genome sequencing and variant calling

Whole genome sequencing was performed by MedGenome (CA, USA) using the HiSeq X Ten platform (Illumina, USA) utilizing a 150 base-pair (bp) paired-end protocol. The raw FASTQ files were evaluated using FastQC software (Babraham Institute, UK). A proprietary WGS data processing pipeline was designed to process NGS data in automated mode from raw FASTQ files to finalized genotyping data. The pipeline implemented adapter trimming using Trimmomatic [9], BWA MEM [10] alignment to the GRCh38 build of the human genome, duplicate reads marking by Picard (Broad Institute, USA), filtering of the resulting SAM/BAM files via SAMtools [11, 12]. It also utilized GATK tools (Broad Institute, USA) to perform base quality score recalibration (BQSR), genotype calling and variant quality score recalibration (VQSR). GATK VariantAnnotator and BCFtools were employed to perform variant annotation. The pipeline implemented several hard filtering procedures resulting in a final VCF output with all variant and non-variant sites which passed quality control of the filtering step. The pipeline was designed in compliance with GATK Best Practices recommendations for NGS data processing. Single nucleotide variants (SNVs) and indels were called using GATK HaplotypeCaller with subsequent VQSR using a threshold of 99.9, HapMap 3.3, 1000G Omni 2.5, 1000G Phase 1 High Confidence and dbSNP build 151 training sets for SNV mode and Mills and 1000G Gold Standard Indels with dbSNP build 151 training sets for INDEL mode.

Quality metrics and validation statistics

Concordance analysis implied calculation of specificity, sensitivity, precision, accuracy, genotype concordance, non-reference genotype concordance and non-reference sensitivity of genotyping between BeadChip and WGS. The analysis implemented confusion matrices calculation (Fig. 6). As there is no baseline “truth” when a WGS call set is compared with a BeadChip one, no method can be described as “comparator”. Because of this, each call set within each pair was treated as alternating “truth” or “test” call set, followed by the averaging of obtained statistics. Filling those matrices with observed numbers of class counts was followed by dimensionality reduction, which implied leaving one class in both call sets intact and combining the counts in all other classes (Fig. 6). The above-specified quality metrics for the initial and reduced matrices were calculated, as shown in Fig. 7 [2] with amendments. As each non-reduced matrix produced 6 submatrices, the calculated sensitivity and precision value for each submatrix was weighted by the fraction of analyzed elements in a non-reduced matrix (i.e., each calculated metric was then multiplied by the ratio of orange-outlined elements to all elements in the reduced matrix in Fig. 7). Such an approach was only necessary for precision and sensitivity metrics due to the fact that these metrics were calculated on non-overlapping subsets of the initial matrix and their values depended on the size of those subsets, given uneven marker distribution in the initial matrix. Other used metrics (accuracy, specificity) were calculated as mean values between 6 produced metric values (excluding NANs, which originated from calculations involving division by zero).
Fig. 6

Example calculation of confusion matrices. The shown dimensionality reduction is used for accuracy and other metrics calculation; a, b, c, d, …, ai, aj — sample counts of each class; A/A, A/B, B/B, A/C, B/C, C/C — diploid genotypes observed in data; A — reference allele, B and C — alternative alleles. TRUTH — a call set produced by an orthogonal method (comparator), TEST — a call set produced by a test method

Fig. 7

Quality metrics calculation for the initial and the “reduced confusion” matrices. Each metric is calculated as a ratio of blue elements to orange-outlined elements; A/A, A/B, B/B, A/C, B/C, C/C — diploid genotypes observed in data; A — reference allele, B and C — alternative alleles; N/N — any diploid genotype category (A/A, A/B, B/B, A/C, B/C, C/C). TRUTH — a call set produced by an orthogonal method (comparator), TEST — a call set produced by a test method

Example calculation of confusion matrices. The shown dimensionality reduction is used for accuracy and other metrics calculation; a, b, c, d, …, ai, aj — sample counts of each class; A/A, A/B, B/B, A/C, B/C, C/C — diploid genotypes observed in data; A — reference allele, B and C — alternative alleles. TRUTH — a call set produced by an orthogonal method (comparator), TEST — a call set produced by a test method Quality metrics calculation for the initial and the “reduced confusion” matrices. Each metric is calculated as a ratio of blue elements to orange-outlined elements; A/A, A/B, B/B, A/C, B/C, C/C — diploid genotypes observed in data; A — reference allele, B and C — alternative alleles; N/N — any diploid genotype category (A/A, A/B, B/B, A/C, B/C, C/C). TRUTH — a call set produced by an orthogonal method (comparator), TEST — a call set produced by a test method All concordant and discordant genotyped variants were analyzed for genotyping quality metrics provided in the VCF files and GenomeStudio report files for WGS and BeadChip genotyping, respectively. The following quality metrics obtained via WGS genotyping pipeline were analyzed: DP variant read depth at a particular position for a particular sample. QUAL Phred-scaled quality score for the assertion made in ALT. i.e., −10log(P), if ALT is “.” (no variant) then this is –10log(P), and if ALT is not “.” this is –10log(P). RGQ unconditional reference genotype confidence, encoded as a Phred quality –10log(P). GQ conditional genotype quality, encoded as a Phred quality –10log(P), conditioned on the site is variant. The following metrics were extracted from corresponding GenomeStudio reports: GC score GenCall score, a quality metric that indicates the reliability of each genotype call. The GenCall Score is a value between 0 and 1 assigned to every called genotype. Genotypes with lower GenCall scores are located further from the centre of a cluster and have lower reliability. GT score GenTrain score, a quality metric that indicates how well the samples clustered for a locus. Cluster Sep cluster separation score. Theta — the normalized Theta-value of the SNP for the sample. R — the normalized R-value of the SNP for the sample. X — the normalized intensity of the A allele. Y — the normalized intensity of the B allele. B Allele Freq B allele theta value of the SNP for the sample, relative to the cluster positions. This value is normalized so that it is zero if theta is less than or equal to the AA cluster’s theta mean, 0.5 if it is equal to the AB cluster’s theta mean, or 1 if it is equal to or greater than the BB cluster’s theta mean. B Allele Freq is linearly interpolated between 0 and 1.

Variant selection for sanger sequencing

An intersection of WGS- and array-genotyped markers which exhibited discordant calls between the two platforms was used for selection. A sliding window approach was utilized to find regions spanning no more than 500 bp (Sanger sequencing reasonable read length limit) and encompassing as many discordant variants from the selected set as possible. All primers for PCR amplification were designed using NCBI Primer-BLAST suite [7] with default parameters (except the melting temperature limits of 58–62 °C) and the human genome reference sequence for BLAST. PCR product lengths and primer lengths were manually optimized to find the most suitable unique match. Primer synthesis, amplification and Sanger sequencing was performed by Evrogen (Russia, Moscow). Sanger chromatograms were visualized and analyzed using 4Peaks software (Nucleobytes, The Netherlands) and CodonCode Aligner (CodonCode Corp., USA) with default trimming and quality filtering parameters. Additional file 1. FastQC report for forward reads. Additional file 2. FastQC report for reverse reads. Additional file 3. FastQC report for forward reads. Additional file 4. FastQC report for reverse reads. Additional file 5. FastQC report for forward reads. Additional file 6. FastQC report for reverse reads.
  10 in total

1.  Whole genome genotyping technologies on the BeadArray platform.

Authors:  Frank J Steemers; Kevin L Gunderson
Journal:  Biotechnol J       Date:  2007-01       Impact factor: 4.677

2.  A statistical framework for SNP calling, mutation discovery, association mapping and population genetical parameter estimation from sequencing data.

Authors:  Heng Li
Journal:  Bioinformatics       Date:  2011-09-08       Impact factor: 6.937

3.  The Sequence Alignment/Map format and SAMtools.

Authors:  Heng Li; Bob Handsaker; Alec Wysoker; Tim Fennell; Jue Ruan; Nils Homer; Gabor Marth; Goncalo Abecasis; Richard Durbin
Journal:  Bioinformatics       Date:  2009-06-08       Impact factor: 6.937

4.  Systematic Evaluation of Sanger Validation of Next-Generation Sequencing Variants.

Authors:  Tyler F Beck; James C Mullikin; Leslie G Biesecker
Journal:  Clin Chem       Date:  2016-02-04       Impact factor: 8.327

5.  Assuring the quality of next-generation sequencing in clinical laboratory practice.

Authors:  Amy S Gargis; Lisa Kalman; Meredith W Berry; David P Bick; David P Dimmock; Tina Hambuch; Fei Lu; Elaine Lyon; Karl V Voelkerding; Barbara A Zehnbauer; Richa Agarwala; Sarah F Bennett; Bin Chen; Ephrem L H Chin; John G Compton; Soma Das; Daniel H Farkas; Matthew J Ferber; Birgit H Funke; Manohar R Furtado; Lilia M Ganova-Raeva; Ute Geigenmüller; Sandra J Gunselman; Madhuri R Hegde; Philip L F Johnson; Andrew Kasarskis; Shashikant Kulkarni; Thomas Lenk; C S Jonathan Liu; Megan Manion; Teri A Manolio; Elaine R Mardis; Jason D Merker; Mangalathu S Rajeevan; Martin G Reese; Heidi L Rehm; Birgitte B Simen; Joanne M Yeakley; Justin M Zook; Ira M Lubin
Journal:  Nat Biotechnol       Date:  2012-11       Impact factor: 54.908

6.  ACMG clinical laboratory standards for next-generation sequencing.

Authors:  Heidi L Rehm; Sherri J Bale; Pinar Bayrak-Toydemir; Jonathan S Berg; Kerry K Brown; Joshua L Deignan; Michael J Friez; Birgit H Funke; Madhuri R Hegde; Elaine Lyon
Journal:  Genet Med       Date:  2013-07-25       Impact factor: 8.822

7.  Primer-BLAST: a tool to design target-specific primers for polymerase chain reaction.

Authors:  Jian Ye; George Coulouris; Irena Zaretskaya; Ioana Cutcutache; Steve Rozen; Thomas L Madden
Journal:  BMC Bioinformatics       Date:  2012-06-18       Impact factor: 3.169

8.  Analytical validation of whole exome and whole genome sequencing for clinical applications.

Authors:  Michael D Linderman; Tracy Brandt; Lisa Edelmann; Omar Jabado; Yumi Kasai; Ruth Kornreich; Milind Mahajan; Hardik Shah; Andrew Kasarskis; Eric E Schadt
Journal:  BMC Med Genomics       Date:  2014-04-23       Impact factor: 3.063

Review 9.  The role and challenges of exome sequencing in studies of human diseases.

Authors:  Zuoheng Wang; Xiangtao Liu; Bao-Zhu Yang; Joel Gelernter
Journal:  Front Genet       Date:  2013-08-26       Impact factor: 4.599

10.  Trimmomatic: a flexible trimmer for Illumina sequence data.

Authors:  Anthony M Bolger; Marc Lohse; Bjoern Usadel
Journal:  Bioinformatics       Date:  2014-04-01       Impact factor: 6.937

  10 in total
  3 in total

1.  Frequency of allele variations in the CFTR gene in a Mexican population.

Authors:  Consuelo Cantú-Reyna; Roberto Galindo-Ramírez; Mercedes Vázquez-Cantú; Lorenza Haddad-Talancón; Willebaldo García-Muñoz
Journal:  BMC Med Genomics       Date:  2021-11-05       Impact factor: 3.063

2.  GAWMerge expands GWAS sample size and diversity by combining array-based genotyping and whole-genome sequencing.

Authors:  Ravi Mathur; Fang Fang; Nathan Gaddis; Dana B Hancock; Michael H Cho; John E Hokanson; Laura J Bierut; Sharon M Lutz; Kendra Young; Albert V Smith; Edwin K Silverman; Grier P Page; Eric O Johnson
Journal:  Commun Biol       Date:  2022-08-11

3.  Comparing BeadChip and WGS Genotyping: Non-Technical Failed Calling Is Attributable to Additional Variation within the Probe Target Sequence.

Authors:  Moran Gershoni; Andrey Shirak; Rotem Raz; Eyal Seroussi
Journal:  Genes (Basel)       Date:  2022-03-09       Impact factor: 4.096

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.